Will a Kidney Transplant Fail? Genes Could Hold the Key

New research shows how expression of certain genes might offer doctors a warning sign when a kidney transplant is poised to fail.

8:00 AM

Author | Kevin Joy

When a patient gets a new kidney, there's no guarantee that the body will accept the foreign organ.

Even with a suitable donor, "it is very complicated and very unpredictable," says Randall Sung, M.D., surgical director of kidney and pancreas transplantation at the University of Michigan Health System.

A recipient's age, immune system and adherence to medication all play a role going forward. And about half of such transplants, regardless of circumstance, are rejected by the body within 10 years.

Which is why Sung and other doctors recently asked the question: How can signs of rejection be identified early enough before the damage is done?  

Key indicators, a multi-center study found, could lie within expression of proteins crucial to the immune response.

Findings by the Scripps Research Institute published last month in the American Journal of Transplantation, attained using genetic expression profiling, which measures the simultaneous activity of thousands of genes, found surprising similarities between cases of early acute kidney rejection (that is, within a year of transplant) and chronic ones that occurred years after the fact.

At present, those two types of rejection are viewed as separate diseases.

Yet, recent biopsies of 234 kidney transplant patients (including eight treated at U-M) revealed that 80 percent of the same genes were highly expressed in both acute and chronic rejection samples.

A second game-changer in the study was the element of interstitial fibrosis and tubular atrophy (IFTA). 

A type of kidney damage and scarring that can result from a past injury, IFTA in otherwise healthy patients was found to share a similar gene expression with those who experienced acute rejection. This was the case even when there were no signs of active immune injury in biopsy specimens.

IFTA has long been associated with an increased risk of transplant failure, but never thought to be a direct sign of active rejection.

That suggests both conditions occupy different parts of the arc on the same immune rejection process, says Sung, who was a site investigator on the study.

Viewed in that context, it could give doctors new clues to predict — and hopefully thwart — rejection, regardless of when the transplant took place. 

"To be able to jump on an evolving [diagnosis of] rejection at its sort of basic molecular genesis, if you will, is the real long-term goal of this type of work," says Sung.

To routinely use this molecular profiling technology as a diagnostic test in your garden variety transplant center is certainly a vision that's coming closer.
Randall Sung, M.D.

Pinpointing problems

The study maintains that transplant organ failure can be tied to inadequate immunosuppression.

Drugs to help the body dial back its immune system's fighting response and allow a new kidney to function are administered to new transplant patients. Acute rejections, as such, are often treated with a higher dose of medication.

The newly discovered link in immune activity between both acute and chronic rejection, then, might help treat the latter condition assumed to be untreatable using those drugs — and, ideally, curb the need for costly and often-complicated dialysis.

Now, Sung says, "you might be more inclined to treat someone for rejection even in the presence of chronic changes."

As a result, researchers on the study have called for more surveillance biopsies to keep closer tabs on post-transplant patients.

But Sung says it might be difficult to determine a proper frequency to make the procedure worthwhile — and noted that it's often difficult to get patients to come in even for the routine blood tests to measure creatinine levels.

Still, the findings show promise.

"About 10 or 15 years ago, these endeavors were felt to be fishing expeditions," Sung says. "To routinely use this molecular profiling technology as a diagnostic test in your garden variety transplant center is certainly a vision that's coming closer."

More Articles About: Body Work Kidney Failure Kidney Disease
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories Doctor talking with patient on hospital bed showing kidney X-ray, blue background
Health Lab
Kidney disease is a problem for cerebral palsy patients. Why are doctors missing it?
Researchers say new measures of kidney function are needed for people with the condition, which is caused by damage to, or malformation of, the developing brain.
Illustration of red blood cells and bacteria in the bloodstream
Health Lab
New device can treat injury from sepsis
The FDA approved the use of a therapeutic device invented and developed at the University of Michigan for use in children with acute kidney injury and sepsis or a septic condition requiring continuous kidney replacement therapy.
Dinero is back to being an active toddler following a kidney transplant
Health Lab
Formula prescription helps 2-year-old receive kidney transplant
Dinero's pediatric nephrology team developed a tailored formula to address his mineral deficiencies due to his chronic kidney disease, maintain nutritional health and avoid dialysis.
supar molecule teal blue yellow red
Health Lab
Immune protein suPAR links viral infection as possible cause of kidney disease
Through a series of experiments in non-human primates, mice and humans, a multi-institutional team led by researchers from Michigan Medicine and Rush University found that the immune protein soluble urokinase plasminogen activator receptor, or suPAR, is an important link between viral infections and proteinuria; the elevation of protein in the urine is known to cause glomerulopathy, a common form of kidney disease.
person in phone and people looking
Health Lab
Despite social media claims, Borax is not safe to consume
A Michigan Medicine explains a dangerous TikTok trend about Borax
gloved hand doing microplate samples
Health Lab
Study brings insight to kidney cancer with gene mutation
A study from clinicians and researchers at the University of Michigan Rogel Cancer Center reveals findings from over 800 clinical assays performed for kidney patients with MiTF family gene mutations.